|
BR112023012656A2
(enExample)
|
|
|
|
CL2025002714A1
(es)
|
|
Receptor de linfocitos t con especificidad para prame presentado en hla-a2; composición farmacéutica; y uso.
|
|
BR112021014123A2
(enExample)
|
|
|
|
BR112022009896A2
(enExample)
|
|
|
|
BR112021017747A2
(enExample)
|
|
|
|
BR112023011738A2
(enExample)
|
|
|
|
BR102021018859A2
(enExample)
|
|
|
|
BR102021015500A2
(enExample)
|
|
|
|
BR112023016292A2
(enExample)
|
|
|
|
BR112023011539A2
(enExample)
|
|
|
|
BR112023011610A2
(enExample)
|
|
|
|
BR102021020147A2
(enExample)
|
|
|
|
BR102021018926A2
(enExample)
|
|
|
|
BR102021018167A2
(enExample)
|
|
|
|
BR102021017576A2
(enExample)
|
|
|
|
BR102021016837A2
(enExample)
|
|
|
|
BR102021016551A2
(enExample)
|
|
|
|
BR102021016375A2
(enExample)
|
|
|
|
BR102021016200A2
(enExample)
|
|
|
|
BR102021016176A2
(enExample)
|
|
|
|
BR102021015566A2
(enExample)
|
|
|
|
BR102021015450A8
(enExample)
|
|
|
|
BR102021015220A2
(enExample)
|
|
|
|
BR102021015247A2
(enExample)
|
|
|
|
BR102021014044A2
(enExample)
|
|
|